Journal of Clinical Endocrinology & Metabolism, Vol 67, 144-148, Copyright © 1988 by Endocrine Society

ARTICLES

Hyperinsulinemia and stromal luteinization of the ovaries in postmenopausal women with endometrial cancer

M Nagamani, EV Hannigan, TV Dinh and CA Stuart
Department of Obstetrics and Gynecology, University of Texas Medical Branch, Galveston 77550.

Ovarian secretion of testosterone and androstenedione is increased in postmenopausal women with endometrial cancer, and insulin stimulates ovarian stromal androgen synthesis in vitro. We undertook this study to investigate whether women with endometrial cancer have increased serum immunoreactive insulin levels. Ten postmenopausal women with endometrial carcinoma and 10 postmenopausal women without cancer who matched the cancer patients in age, years since menopause, and percentage of ideal body weight were studied. The women with endometrial cancer had significantly higher fasting serum insulin levels than the normal women [mean, 187 +/- 26 (+/- SE) vs. 55 +/- 11 pmol/L; P less than 0.01]. The cancer patients had significantly higher insulin responses after glucose administration than normal women (sum of 1, 2, and 3 h postglucose values, 5545 +/- 1526 vs. 1444 +/- 156 pmol/L; P less than 0.02), even though their glucose responses were similar. Nests of luteinized cells, which were positive for testosterone by immunoperoxidase staining, were found in the ovarian stroma of 8 of the women with endometrial cancer, but in only 1 of those without cancer (P less than 0.01). Specific high affinity insulin receptors were demonstrable in the stroma of the postmenopausal ovaries. These results suggest that the frequency of stromal luteinization is increased in women with endometrial cancer and that insulin may play a role in the pathogenesis of this luteinization.

This article has been cited by other articles:

				E. Petridou, C. Mantzoros, N. Dessypris, P. Koukoulomatis, C. Addy, Z. Voulgaris, G. Chrousos, and D. Trichopoulos Plasma Adiponectin Concentrations in Relation to Endometrial Cancer: A Case-Control Study in Greece J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 993 - 997. [Abstract] [Full Text] [PDF]

				H. Satoh, K. Kai, K. Yabe, F. Fuj, and K. Furuhama Mullerian Tumor (Atypical Polypoid Adenomyoma) with Sex-Cord Differentiation Arising from the Oviduct in an Adolescent Cynomolgus Monkey (Macaca fascicularis) Toxicol Pathol, February 1, 2003; 31(2): 179 - 184. [Abstract] [PDF]

				M. Nagamani and R. J. Urban Expression of Messenger Ribonucleic Acid Encoding Steroidogenic Enzymes in Postmenopausal Ovaries Reproductive Sciences, January 1, 2003; 10(1): 37 - 40. [Abstract] [PDF]

				G. E. Hale, C. L. Hughes, and J. M. Cline Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15. [Abstract] [Full Text] [PDF]

				M. Nagamani, C. Osuampke, and M. E. Kelver Increased Bioactive Luteinizing Hormone Levels and Bio/Immuno Ratio in Women with Hyperthecosis of the Ovaries: Possible Role of Hyperinsulinemia J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1685 - 1689. [Abstract] [Full Text]